Medtronic has reported better-than-expected earnings of $9.02 billion for Q3, yet its stock has dropped approximately 13% over the past month, currently trading at $78.32. The company's stock reflects broader market volatility, with a 52-week price range between $74.40 and $106.33, as analysts express mixed feelings, lowering price targets amid investor concerns. As Medtronic seeks to bolster its portfolio with a $650 million acquisition of SPR Therapeutics, it remains under scrutiny due to a pending class action lawsuit.
“Medtronic · posts · better-than-expected earnings · but stock is falling”
“Medtronic plc. · has stock price · current price · $78.32”
“Medtronic plc. · has bid price · current bid · $78.31”
“Medtronic plc. · has ask price · current ask · $78.33”
“Medtronic plc. · has volume · current volume · 1,310,541.403973”
“Medtronic plc. · has 52 week range · 52 week range · 74.40 - 106.33”
“Medtronic plc. · has high/low · high/low · 78.28 - 79.25”
“MDT · is trading at · a 52% premium”
“Medtronic · has historically held · roughly 50% share in its core heart devices”
“Medtronic · is the market leader in · spinal products, insulin pumps, and neuromodulators for chronic pain”
“Medtronic · develops and manufactures · therapeutic medical devices for chronic diseases”
“Price/Earnings (Normalized) · is · 14.11 · MDT”
